HIV in Canada—Supplementary tables, 2016

Volume 43-12, December 7, 2017: Can we eliminate HIV?

Web exclusive

HIV in Canada—Supplementary tables, 2016

AC Bourgeois¹, M Edmunds¹, A Awan^1,2, L Jonah¹, O Varsaneux¹, W Siu¹

Affiliations

¹ Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON

² Dalla Lana School of Public Health, University of Toronto, Toronto, ON

Correspondence

HASS@phac-aspc.gc.ca

Suggested citation

AC Bourgeois, M Edmunds, A Awan, L Jonah, O Varsaneux, W Siu. HIV in Canada – Supplementary tables, 2016. Can Commun Dis Rep. 2017;43(12). Web exclusive. https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-12-december-7-2017/hiv-2016-supplementary-tables.html

This article provides supplementary data for the surveillance report in this issue entitled: HIV in Canada—Surveillance Report, 2016^{Footnote 1}

Subscribe to CCDR

Submit a manuscript

About CCDR

Browse

Past issues

Table 1: HIV diagnosis rate (per 100,000 population) by province/territory and year of test (all ages)—Canada, 2007-2016^{Footnote *} ^{Footnote †}
Province/Territory	Year of test
Province/Territory	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016
British Columbia
Male	14.2	13.2	12.1	10.7	10.9	9.2	10.2	9.3	8.6	9.0
Female	3.9	2.7	3.2	2.7	1.9	1.3	1.3	1.9	1.6	1.7
Total	9.1	7.9	7.6	6.7	6.4	5.2	5.7	5.6	5.1	5.3
Yukon
Male	0.0	5.9	11.5	0.0	5.5	5.4	5.4	10.6	5.3	0.0
Female	0.0	6.2	6.0	5.9	0.0	0.0	0.0	5.5	0.0	10.8
Total	0.0	6.0	8.8	2.9	2.8	2.8	2.8	8.1	2.7	5.3
Alberta
Male	8.8	8.2	8.0	7.8	8.0	8.7	8.8	9.2	6.9	9.1
Female	3.9	4.6	3.8	3.0	3.7	3.6	4.0	4.5	4.3	4.0
Total	6.4	6.4	5.9	5.4	5.9	6.2	6.5	6.9	5.6	6.6
Northwest Territories
Total	DS	DS	DS	DS	DS	DS	DS	DS	DS	DS
Nunavut
Total	DS	DS	DS	DS	DS	DS	DS	DS	DS	DS
Saskatchewan
Male	13.0	18.7	21.2	20.6	20.3	19.8	15.6	13.9	18.0	16.5
Female	12.2	15.4	17.1	12.5	14.8	13.8	8.0	7.9	11.0	13.6
Total	12.6	17.0	19.1	16.6	17.6	16.9	11.8	10.9	14.5	15.1
Manitoba
Male	8.6	8.9	9.5	13.8	7.7	6.7	11.3	8.4	10.8	13.0
Female	4.0	5.8	7.5	6.0	4.8	4.6	7.4	5.1	5.4	6.0
Total	6.3	7.3	8.5	9.9	6.2	5.7	9.3	6.8	8.1	9.5
Ontario
Male	12.4	12.7	11.6	12.3	11.7	10.1	9.9	9.7	9.9	10.1
Female	3.5	4.0	3.2	2.7	3.0	2.7	1.9	2.4	2.3	2.5
Total	7.9	8.4	7.4	7.5	7.4	6.4	5.9	6.0	6.1	6.3
Quebec^{Footnote ‡}
Male	10.6	12.7	10.2	9.1	9.3	8.7	8.4	7.9	8.7	11.5
Female	3.2	3.7	2.9	2.9	2.6	2.2	2.6	2.7	2.7	2.8
Total	6.9	8.2	6.5	6.0	5.9	5.5	5.5	5.3	5.7	7.1
New Brunswick
Male	2.5	2.7	0.3	2.1	2.1	1.1	1.6	0.8	1.3	0.5
Female	1.3	1.1	0.0	0.0	0.5	0.0	0.0	0.3	1.0	1.3
Total	1.9	1.9	0.1	1.1	1.3	0.5	0.8	0.5	1.2	0.9
Nova Scotia
Male	4.0	4.2	2.4	2.6	2.8	3.9	2.8	2.8	3.2	2.4
Female	0.4	0.4	0.4	0.6	0.4	0.0	0.6	0.0	0.4	0.6
Total	2.1	2.2	1.4	1.6	1.6	1.9	1.7	1.4	1.8	1.5
Prince Edward Island
Total	DS	DS	DS	DS	DS	DS	DS	DS	DS	DS
Newfoundland and Labrador^{Footnote §}
Male	0.0	0.8	1.6	1.3	0.8	1.9	1.6	2.7	2.7	1.9
Female	0.0	0.0	0.0	0.0	0.0	0.7	0.4	1.1	0.4	0.4
Total	0.0	0.6	1.2	1.0	0.6	1.7	1.3	2.5	2.1	1.5
Grand Total	7.3	7.8	7.0	6.7	6.6	5.9	5.8	5.8	5.8	6.4
Grand total males	11.7	11.5	10.4	10.3	10.0	9.1	9.1	8.7	8.8	9.8
Grand total females	3.6	4.0	3.6	3.1	3.1	2.7	2.5	2.8	2.8	3.0
Table 1 footnotes Table 1 Abbreviation Abbreviation: DS, Data Suppressed Table 1 footnote * Population data source: Annual Demographic Statistics, Demography Division, Statistics Canada, October 2016 Return to Table 1 footnote * referrer Table 1 footnote † Reporting of HIV cases for individuals younger than two years of age varies among provinces and territories Return to Table 1 footnote † referrer Table 1 footnote ‡ For Quebec, the number of HIV cases is based on the minimum number of HIV-positive individuals Return to Table 1 footnote ‡ referrer Table 1 footnote § Before 2011, HIV cases diagnosed outside of Newfoundland and Labrador were not included in Newfoundland and Labrador's surveillance data Return to Table 1 footnote § referrer

Table 2: Number of HIV cases (all ages) by province/territory, sex and year of test—Canada, 1985-2016^{Footnote *}
Province/territory	Year of test						Total
Province/territory	1985-2011	2012	2013	2014	2015	2016	n	%^{Footnote ¥}
British Columbia
Male	11,841	208	234	215	202	213	12,913	19.4
Female	2,089	29	31	44	37	40	2,270	14.9
Total	14,274	237	265	261	239	253	15,529	18.4
Yukon
Male	39	1	1	2	1	0	44	0.1
Female	16	0	0	1	0	2	19	0.1
Total	55	1	1	3	1	2	63	0.1
Alberta
Male	4,471	173	180	193	148	197	5,362	8.1
Female	1,204	69	80	91	89	84	1,617	10.6
Total	5,675	242	261	284	237	282	6,981	8.3
Northwest Territories
Male	DS	DS	DS	DS	DS	DS	45	0.1
Female	DS	DS	DS	DS	DS	DS	12	0.1
Total	51	DS	DS	DS	DS	DS	57	0.1
Nunavut^{Footnote †}
Male	DS	DS	DS	DS	DS	DS	4	0.0
Female	DS	DS	DS	DS	DS	DS	0	0.0
Total	DS	DS	DS	DS	DS	DS	6	0.0
Saskatchewan
Male	936	109	87	79	103	96	1,410	2.1
Female	618	75	44	44	62	78	921	6.1
Total	1,564	184	131	123	165	174	2,341	2.8
Manitoba
Male	1,337	42	71	54	70	86	1,660	2.5
Female	506	29	47	33	35	40	690	4.5
Total	1,843	71	118	87	105	126	2,350	2.8
Ontario
Male	26,236	670	659	655	674	696	29,590	44.5
Female	4,867	186	132	167	161	177	5,690	37.4
Total	32,113	861	797	828	839	881	36,319	43.0
Quebec^{Footnote ‡}
Male	12,305	351	342	322	359	476	14,155	21.3
Female	3,203	91	107	113	114	117	3,745	24.6
Total	16,714	443	453	435	473	593	19,111	22.6
New Brunswick
Male	354	4	6	3	5	2	374	0.6
Female	60	0	0	1	4	5	70	0.5
Total	414	4	6	4	9	7	444	0.5
Nova Scotia
Male	659	18	13	13	15	11	729	1.1
Female	106	0	3	0	2	3	114	0.7
Total	765	18	16	13	17	14	843	1.0
Prince Edward Island
Male	DS	DS	DS	DS	DS	DS	32	0.0
Female	DS	DS	DS	DS	DS	DS	9	0.1
Total	44	DS	DS	DS	DS	DS	53	0.1
Newfoundland and Labrador^{Footnote §}
Male	210	7	6	10	10	7	250	0.4
Female	54	2	1	3	1	1	62	0.4
Total	264	9	7	13	11	8	312	0.4
Grand Total	73,779	2,073	2,060	2,053	2,100	2,344	84,409	100
Grand total male	58,456	1,584	1,603	1,548	1,589	1,788	66,568	100
Grand total female	12,741	483	446	497	505	547	15,219	100
Table 2 footnotes Table 2 Abbreviation Abbreviation: DS, Data Suppressed; %, percentage Table 2 footnote * Reporting of HIV cases for individuals younger than two years of age varies among provinces and territories Return to Table 2 footnote * referrer Table 2 footnote † Data for Nunavut before 2000 are not available. Nunavut became a Canadian territory in April 1999 and began reporting in 2000 Return to Table 2 footnote † referrer Table 2 footnote ‡ For Quebec, the number of HIV cases is based on the minimum number of HIV-positive individuals Return to Table 2 footnote ‡ referrer Table 2 footnote § Before 2011, HIV cases diagnosed outside of Newfoundland and Labrador were not included in Newfoundland and Labrador's surveillance data Return to Table 2 footnote § referrer Table 2 footnote ¥ Percentages are calculated based on the total of their respective category Return to Table 2 footnote ¥ referrer

Table 3: Number of HIV cases by age group and province/territory—Canada, 2015-2016^{Footnote *}
Province/territory	Age group (years)						Total
Province/territory	Under 15	15-19	20-29	30-39	40-49	50 and up	n
2016
British Columbia	0	4	66	71	43	68	252
Yukon	0	0	0	1	0	1	2
Alberta	1	7	62	98	65	49	282
Northwest Territories	DS	DS	DS	DS	DS	DS	DS
Nunavut	DS	DS	DS	DS	DS	DS	DS
Saskatchewan	1	6	42	54	36	35	174
Manitoba	1	3	20	33	42	27	126
Ontario	8	18	217	261	184	191	879
Quebec†	2	10	106	148	135	192	593
New Brunswick	0	0	2	2	1	2	7
Nova Scotia	0	0	7	1	6	0	14
Prince Edward Island	DS	DS	DS	DS	DS	DS	DS
Newfoundland and Labrador^{Footnote ‡}	0	0	2	2	2	2	8
2016 Total^{Footnote §} ^{Footnote ¥}	13	48	526	672	514	568	2,341
2015
British Columbia	0	5	57	57	51	69	239
Yukon	0	0	0	1	0	0	1
Alberta	1	5	57	73	60	41	237
Northwest Territories	DS	DS	DS	DS	DS	DS	DS
Nunavut	DS	DS	DS	DS	DS	DS	DS
Saskatchewan	4	4	43	45	35	34	165
Manitoba	0	1	25	22	34	23	105
Ontario	4	18	235	239	178	165	839
Quebec^{Footnote †}	3	6	87	128	88	161	473
New Brunswick	0	0	2	1	1	5	9
Nova Scotia	0	1	10	3	3	0	17
Prince Edward Island	DS	DS	DS	DS	DS	DS	DS
Newfoundland and Labrador^{Footnote ‡}	0	0	2	3	4	2	11
2015 Total^{Footnote ¥}	12	40	518	573	454	501	2,098
Table 3 footnotes Table 3 Abbreviation Abbreviation: DS, Data Suppressed Table 3 footnote * Reporting of HIV cases for individuals younger than two years of age varies among provinces and territories Return to Table 3 footnote * referrer Table 3 footnote † For Quebec, the number of HIV cases is based on the minimum number of HIV-positive individuals Return to Table 3 footnote † referrer Table 3 footnote ‡ Before 2011, HIV cases diagnosed outside of Newfoundland and Labrador were not included in Newfoundland and Labrador's surveillance data Return to Table 3 footnote ‡ referrer Table 3 footnote § Missing three cases with age not reported Return to Table 3 footnote § referrer Table 3 footnote ¥ Missing two cases with age not reported Return to Table 3 footnote ¥ referrer

Table 4: Cumulative number of HIV cases among adults (≥15 years old) and children (< 15 years old) by sex between November 1, 1985 and December 31, 2016—Canada^{Footnote *}
Age and sex	Number of cases reported	%^{Footnote †}
Children (< 15 years old)
Males	364	56.4
Females	281	43.6
Sex not reported/other	12	n/a
Total	657	0.8
Adults (≥15 years old)^{Footnote ‡}
Males	64,127	81.3
Females	14,758	18.7
Sex not reported/other	1,249	n/a
Total	80,134	99.2
Age group not reported
Males	2,077	n/a
Females	180	n/a
Sex not reported/other	1,361	n/a
Total	3,618	n/a
Total
Males	66,568	81.4
Females	15,219	18.6
Sex not reported/other	2,622	n/a
Grand Total	84,409	100.0
Table 4 footnotes Table 4 Abbreviations Abbreviations: n/a, not applicable; %, percentage Table 4 footnote * Reporting of HIV cases for individuals younger than two years of age varies among provinces and territories Return to Table 4 footnote * referrer Table 4 footnote † Percentages are based on the total number excluding "sex not reported/transsexual/transgender" Return to Table 4 footnote † referrer Table 4 footnote ‡ Between 1985 and 1996, Alberta reported 47 HIV cases that were children (<15 years old). However due to limitations with the data, these cases are reported as "Adults (>15 years old)" Return to Table 4 footnote ‡ referrer

Table 5: Number of HIV cases among adults (≥15 years old) by year of test and sex—Canada, 1985-2016
Year of diagnosis	Males		Females		Sex not reported/ transsexual/transgender		Total
Year of diagnosis	Number of cases	Cumulative total	Number of cases	Cumulative total	Number of cases	Cumulative total	Number of cases	Cumulative total
1985-2005	45,382	45,382	8,752	8,752	1,172	1,172	55,306	55,306
2006	1,793	47,175	683	9,435	6	1,178	2,482	57,788
2007	1,776	48,951	589	10,024	7	1,185	2,372	60,160
2008	1,903	50,854	658	10,682	4	1,189	2,565	62,725
2009	1,740	52,594	593	11,275	6	1,195	2,339	65,064
2010	1,747	54,341	516	11,791	11	1,206	2,274	67,338
2011	1,713	56,054	527	12,318	11	1,217	2,251	69,589
2012	1,574	57,628	476	12,794	5	1,222	2,055	71,644
2013	1,591	59,219	435	13,229	9	1,231	2,035	73,679
2014	1,543	60,762	491	13,720	7	1,238	2,041	75,720
2015	1,584	62,346	498	14,218	4	1,242	2,086	77,806
2016	1,781	64,127	540	14,758	7	1,249	2,328	80,134
*Total^{Footnote }**	64,127	n/a	14,758	n/a	1,249	n/a	80,134	n/a
Table 5 footnotes Table 5 Abbreviations Abbreviation: n/a, not applicable Table 5 footnote * Between 1985 and 1996, Alberta reported 47 HIV cases that were children (<15 years old). However due to limitations with the data, these cases are reported as "adults (>15 years old)" Return to Table 5 footnote * referrer

Table 6: Number of HIV cases by age group, sex and year of test—Canada, 1985-2016^{Footnote *} ^{Footnote †}
Age and Sex	Year of test												Total
	1985-2011		2012		2013		2014		2015		2016		n	%^{Footnote ‡}
	n	%	n	%	n	%	n	%	n	%	n	%	n	%^{Footnote ‡}
Children < 15 years
Male	330	0.6	9	0.6	10	0.6	4	0.3	5	0.3	6	0.3	364	0.6
Female	243	1.9	7	1.4	11	2.5	6	1.2	7	1.4	7	1.3	281	1.9
Total	585	0.8	16	0.8	21	1.0	10	0.5	12	0.6	13	0.6	657	0.8
15 to 19 years
Male	618	1.1	22	1.4	26	1.6	24	1.6	21	1.3	28	1.6	739	1.1
Female	496	3.9	14	2.9	12	2.7	13	2.6	19	3.8	20	3.7	574	3.8
Total	1,124	1.6	36	1.7	38	1.8	37	1.8	40	1.9	48	2.1	1,323	1.6
20 to 29 years
Male	13,283	23.6	355	22.4	356	22.2	350	22.6	401	25.2	405	22.7	15,150	23.5
Female	3,990	31.5	114	23.6	98	22.0	86	17.3	115	22.8	120	21.9	4,523	29.9
Total	17,544	25.0	471	22.7	455	22.1	438	21.4	518	24.7	526	22.5	19,952	24.7
30 to 39 years
Male	21,909	38.9	438	27.7	437	27.3	470	30.4	416	26.2	495	27.7	24,165	37.5
Female	4,632	36.6	166	34.4	159	35.7	175	35.2	157	31.1	174	31.8	5,463	36.1
Total	26,986	38.5	606	29.3	598	29.1	648	31.6	573	27.3	672	28.7	30,083	37.2
40 to 49 years
Male	13,440	23.8	462	29.2	409	25.5	355	22.9	347	21.8	396	22.2	15,409	23.9
Female	2,196	17.3	113	23.4	100	22.4	113	22.7	107	21.2	115	21.0	2,744	18.1
Total	15,871	22.6	575	27.8	512	24.9	468	22.8	454	21.6	514	22.0	18,394	22.8
≥50 years
Male	6,028	10.7	297	18.8	363	22.7	344	22.2	399	25.1	457	25.6	7,888	12.2
Female	1,015	8.0	69	14.3	66	14.8	104	20.9	100	19.8	111	20.3	1,465	9.7
Total	7,147	10.2	367	17.7	432	21.0	450	21.9	501	23.9	568	24.3	9,465	11.7
Adult, age unknown^{Footnote §}
Male	776	1	0	0	0	0	0	0	0	0	0	0	776	1.2
Female	88	1	0	0	0	0	0	0	0	0	0	0	88	0.6
Total	917	1.3	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	917	1.1
Total all ages
Male	56,384	100	1,583	100	1,601	100	1,547	100	1,589	100	1,787	100	64,491	100
Female	12,659	100	483	100	446	100	497	100	505	100	547	100	15,137	100
Total	70,174	100	2,071	100	2,056	100	2,051	100	2,098	100	2,341	100	80,791	100
Total Adults
Male	56,054	n/a	1,574	n/a	1,591	n/a	1,543	n/a	1,584	n/a	1,781	n/a	64,127	n/a
Female	12,416	n/a	476	n/a	435	n/a	491	n/a	498	n/a	540	n/a	14,856	n/a
Total	69,589	n/a	2,055	n/a	2,035	n/a	2,041	n/a	2,086	n/a	2,328	n/a	80,134	n/a
Age group not reported
Total	3,605	n/a	2	n/a	4	n/a	2	n/a	2	n/a	3	n/a	3,618	n/a
Grand Total	73,779	n/a	2,073	n/a	2,060	n/a	2,053	n/a	2,100	n/a	2,344	n/a	84,409	n/a
Table 6 footnotes Table 6 Abbreviations Abbreviations: n, number; n/a, not applicable; %, percentage Table 6 footnote * Reporting of HIV cases for individuals younger than two years of age varies among provinces and territories Return to Table 6 footnote * referrer Table 6 footnote † All sex categories exclude "sex not reported" and "unknown" Return to Table 6 footnote † referrer Table 6 footnote ‡ Percentages are based on the total number excluding "age group not reported" Return to Table 6 footnote ‡ referrer Table 6 footnote § Between 1985 and 1996, Alberta reported 47 HIV cases that were children (<15 years old). However due to limitations with the data, these cases are reported as "adult, age unknown" Return to Table 6 footnote § referrer

Table 7: Number and percentage distribution of HIV cases among adults (≥15 years old) by exposure category—Canada, 1985-2016^{Footnote *}
Exposure category	Exposure sub-category	Year of test												Total
		1985-2011		2012		2013		2014		2015		2016		n	%^{Footnote †}
		n	%	n	%	n	%	n	%	n	%	n	%	n	%^{Footnote †}
MSM	n/a	21,730	54.2	665	46.7	674	48.4	669	48.5	624	44.9	633	44.1	24,995	53.1
MSM/IDU	n/a	1,039	2.6	30	2.1	38	2.7	38	2.8	43	3.1	55	3.8	1,243	2.6
IDU	n/a	7,009	17.5	215	15.1	186	13.4	183	13.3	225	16.2	216	15.1	8,034	17.1
Blood/blood products^{Footnote ‡}	Recipient of blood/clotting factor	166	0.4	0	0.0	1	0.1	1	0.1	0	0.0	1	0.1	169	0.4
	Recipient of blood	286	0.7	0	0.0	0	0.0	1	0.1	1	0.1	1	0.1	289	0.6
	Recipient of clotting factor	311	0.8	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	311	0.7
Heterosexual contact	Origin from an HIV-endemic country	2,824	7.0	172	12.1	129	9.3	136	9.9	149	10.7	151	10.5	3,561	7.6
	Sexual contact with a person at risk	2,939	7.3	145	10.2	159	11.4	130	9.4	118	8.5	127	8.9	3,618	7.7
	NIR-Het	3,339	8.3	133	9.3	136	9.8	133	9.7	177	12.7	185	12.9	4,103	8.7
Other^{Footnote §}	n/a	445	1.1	63	4.4	70	5.0	87	6.3	54	3.9	66	4.6	785	1.7
Subtotal	n/a	40,088	100	1,423	100	1,393	100	1,378	100	1,391	100	1,435	100	47,108	100
NIR	n/a	3,555	n/a	64	n/a	36	n/a	70	n/a	58	n/a	87	n/a	3,870	n/a
Not reported	n/a	25,946	n/a	568	n/a	606	n/a	593	n/a	637	n/a	806	n/a	29,156	n/a
Total^{Footnote ¶}	n/a	69,589	n/a	2,055	n/a	2,035	n/a	2,041	n/a	2,086	n/a	2,328	n/a	80,134	n/a
Table 7 footnotes Table 7 Abbreviations Abbreviations: IDU, injection drug use; MSM, men who have sex with men; MSM/IDU, men who have sex with men and use injection drugs; n, number; n/a, not applicable; NIR, no identified risk; NIR-Het, no identified risk-heterosexual; %, percentage Table 7 footnote * Exposure category data are not available for Quebec and are incomplete before 2009 for Ontario. These data are presented as "not reported" Return to Table 7 footnote * referrer Table 7 footnote † Percentages are based on the total number excluding "NIR" and "not reported" Return to Table 7 footnote † referrer Table 7 footnote ‡ It is not always possible to separate "recipient of blood" from "recipient of clotting factor". However, they have been separated where possible for reporting purposes Return to Table 7 footnote ‡ referrer Table 7 footnote § For Alberta, cases identified as CIC/OOC were classified in the exposure category of "other" Return to Table 7 footnote § referrer Table 7 footnote ¶ Between 1985 and 1996, Alberta reported 47 HIV cases that were children (<15 years old). However due to limitations with the data, these cases are reported as "adult, age unknown" Return to Table 7 footnote ¶ referrer

Table 8: Number and percentage distribution of HIV cases among adult males (≥15 years old) by exposure category and year of test—Canada, 1985-2016^{Footnote *}
Exposure category	Exposure sub-category	Year of test												Total
		1985-2011		2012		2013		2014		2015		2016		n	%^{Footnote †}
		n	%	n	%	n	%	n	%	n	%	n	%	n	%^{Footnote †}
MSM	n/a	21,641	66.0	665	61.7	674	61.8	669	63.0	624	59.3	633	59.0	24,906	65.3
MSM/IDU	n/a	1,037	3.2	30	2.8	38	3.5	38	3.6	43	4.1	55	5.1	1,241	3.3
IDU	n/a	4,546	13.9	129	12.0	121	11.1	102	9.6	131	12.5	117	10.9	5,146	13.5
Blood/blood products^{Footnote ‡}	Recipient of blood/clotting factor	128	0.4	0	0.0	1	0.1	1	0.1	0	0.0	1	0.1	131	0.3
	Recipient of blood	175	0.5	0	0.0	0	0.0	1	0.1	1	0.1	1	0.1	178	0.5
	Recipient of clotting factor	267	0.8	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	267	0.7
Heterosexual contact	Origin from an HIV-endemic country	1,234	3.8	60	5.6	46	4.2	60	5.6	54	5.1	66	6.2	1,520	4.0
	Sexual contact with a person at risk	1,409	4.3	66	6.1	80	7.3	65	6.1	51	4.8	60	5.6	1,731	4.5
	NIR-Het	2,020	6.2	91	8.4	95	8.7	76	7.2	122	11.6	106	9.9	2,510	6.6
Other^{Footnote §}	n/a	311	0.9	37	3.4	35	3.2	50	4.7	26	2.5	33	3.1	492	1.3
Subtotal	n/a	32,768	100	1,078	100	1,090	100	1,062	100	1,052	100	1,072	100	38,122	100
NIR	n/a	2,761	n/a	49	n/a	31	n/a	46	n/a	48	n/a	69	n/a	3,004	n/a
Not reported	n/a	20,525	n/a	447	n/a	470	n/a	435	n/a	484	n/a	640	n/a	23,001	n/a
Total^{Footnote ¶}	n/a	56,054	n/a	1,574	n/a	1,591	n/a	1,543	n/a	1,584	n/a	1,781	n/a	64,127	n/a
Table 8 footnotes Table 8 Abbreviations Abbreviations: IDU, injection drug user; MSM, men who have sex with men; MSM/IDU, men who have sex with men and use injection drugs; n, number; n/a, not applicable; NIR, no identified risk; NIR-Het, no identified risk-heterosexual; %, percentage Table 8 footnote * Exposure category data are not available for Quebec and are incomplete before 2009 for Ontario. These data are presented as "not reported" Return to Table 8 footnote * referrer Table 8 footnote † Percentages are based on the total number excluding "NIR" and "not reported" Return to Table 8 footnote † referrer Table 8 footnote ‡ It is not always possible to separate "recipient of blood" from "recipient of clotting factor". However, they have been separated where possible for reporting purposes Return to Table 8 footnote ‡ referrer Table 8 footnote § For Alberta, cases identified as CIC/OOC were classified in the exposure category of "Other" Return to Table 8 footnote § referrer Table 8 footnote ¶ Excludes 2,612 HIV cases where sex was not reported or reported as transsexual or transgender Return to Table 8 footnote ¶ referrer

Table 9: Number and percentage distribution of HIV cases among adult females (≥15 years old) by exposure category and year of test—Canada, 1985-2016^{Footnote *}
Exposure category	Exposure sub-category	Year of diagnosis												Total
		1985-2011		2012		2013		2014		2015		2016		n	%^{Footnote †}
		n	%	n	%	n	%	n	%	n	%	n	%	n	%^{Footnote †}
IDU	n/a	2,412	33.8	86	24.9	64	21.3	79	25.3	94	27.7	99	27.3	2,834	32.2
Blood/blood products^{Footnote ‡}	Recipient of blood/clotting factor	38	0.5	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	38	0.4
	Recipient of blood	107	1.5	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	107	1.2
	Recipient of clotting factor	31	0.4	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	31	0.4
Heterosexual contact	Origin from an HIV-endemic country	1,583	22.2	112	32.5	82	27.3	76	24.4	95	28.0	85	23.5	2,033	23.1
	Sexual contact with a person at risk	1,512	21.2	79	22.9	78	26.0	64	20.5	67	19.8	67	18.5	1,867	21.2
	NIR-Het	1,319	18.5	42	12.2	41	13.7	56	17.9	55	16.2	78	21.5	1,591	18.1
Other^{Footnote §}	n/a	130	1.8	26	7.5	35	11.7	37	11.9	28	8.3	33	9.1	289	3.3
Subtotal	n/a	7,132	100	345	100	300	100	312	100	339	100	362	100	8,790	100
NIR	n/a	630	n/a	13	n/a	5	n/a	23	n/a	9	n/a	18	n/a	698	n/a
Not reported	n/a	4,556	n/a	118	n/a	130	n/a	156	n/a	150	n/a	160	n/a	5,270	n/a
Total^{Footnote ¶}	n/a	12,318	n/a	476	n/a	435	n/a	491	n/a	498	n/a	540	n/a	14,758	n/a
Table 9 footnotes Table 9 Abbreviations Abbreviations: IDU, injection drug user; n, number; n/a, not applicable; NIR, no identified risk; NIR-Het, no identified risk-heterosexual; %, percentage Table 9 footnote * Exposure category data are not available for Quebec and are incomplete before 2009 for Ontario. These data are presented as "not reported". Return to Table 9 footnote * referrer Table 9 footnote † Percentages are based on the total number excluding "NIR" and "not reported" Return to Table 9 footnote † referrer Table 9 footnote ‡ It is not always possible to separate "recipient of blood" from "recipient of clotting factor"; however, they have been separated where possible for reporting purposes Return to Table 9 footnote ‡ referrer Table 9 footnote § For Alberta, cases identified as CIC/OOC were classified in the exposure category of "other" Return to Table 9 footnote § referrer Table 9 footnote ¶ Excludes 2,612 HIV cases where sex was not reported or reported as transsexual or transgender Return to Table 9 footnote ¶ referrer

Table 10: Number and percentage distribution of HIV cases among adults (≥15 years old) by exposure category and age group—Canada, 2015-2016^{Footnote *}
Year	Exposure category	Exposure sub-category	Age group (years)
			15-19		20-29		30-39		40-49		≥ 50		Age group not reported		Total
			n	%	n	%	n	%	n	%	n	%	n	%	n	%
2016	MSM	n/a	12	37.5	204	38.8	198	29.5	117	22.8	102	18.0	0	0	633	27.4
	MSM/IDU	n/a	2	6.3	15	2.9	20	3.0	10	1.9	8	1.4	0	0	55	2.4
	IDU	n/a	4	12.5	49	9.3	77	11.5	46	8.9	40	7.0	0	0	216	9.3
	Blood/blood products^{Footnote †}	n/a	0	0.0	1	0.2	0	0.0	0	0.0	1	0.2	0	0	2	0.1
	Heterosexual contact	Origin from an HIV-endemic country	3	9.4	23	4.4	49	7.3	44	8.6	32	5.6	0	0	151	6.5
		Sexual contact with a person at risk	2	6.3	28	5.3	33	4.9	30	5.8	34	6.0	0	0	127	5.5
		NIR-Het	4	12.5	35	6.7	45	6.7	44	8.6	57	10.0	0	0	185	8.0
	Other^{Footnote ‡}	n/a	5	15.6	11	2.1	21	3.1	18	3.5	11	1.9	0	0	66	2.9
	NIR	n/a	0	0.0	11	2.1	20	3.0	27	5.3	27	4.8	0	0	85	3.7
	Not reported	n/a	0	0.0	149	28.3	209	31.1	178	34.6	256	45.1	0	0	792	34.3
	2016 Total	n/a	32	100	526	100	672	100	514	100	568	100	0	100	2,312	100
2015	MSM	n/a	10	25.0	223	43.1	170	29.7	121	26.7	100	20.0	0	0	624	29.9
	MSM/IDU	n/a	0	0.0	17	3.3	13	2.3	6	1.3	7	1.4	0	0	43	2.1
	IDU	n/a	4	10.0	60	11.6	66	11.5	63	13.9	32	6.4	0	0	225	10.8
	Blood/blood products^{Footnote †}	n/a	0	0.0	0	0.0	0	0.0	0	0.0	1	0.2	0	0	1	0.0
	Heterosexual contact	Origin from an HIV-endemic country	5	12.5	21	4.1	47	8.2	41	9.0	35	7.0	0	0	149	7.1
		Sexual contact with a person at risk	5	12.5	19	3.7	28	4.9	27	5.9	39	7.8	0	0	118	5.7
		NIR-Het	5	12.5	31	6.0	46	8.0	40	8.8	55	11.0	0	0	177	8.5
	Other^{Footnote ‡}	n/a	1	2.5	14	2.7	16	2.8	12	2.6	11	2.2	0	0	54	2.6
	NIR	n/a	1	2.5	10	1.9	16	2.8	14	3.1	17	3.4	0	0	58	2.8
	Not reported	n/a	9	22.5	123	23.7	171	29.8	130	28.6	204	40.7	0	0	637	30.5
	2015 Total	n/a	40	100	518	100	573	100	454	100	501	100	0	100	2,086	100
Table 10 footnotes Table 10 Abbreviations Abbreviations: IDU, injection drug user; MSM, men who have sex with men; MSM/IDU, men who have sex with men and use injection drugs; n, number; NIR, no identified risk; NIR-Het, no identified risk-heterosexual; %, percentage Table 10 footnote * Exposure category data are not available for Quebec and are incomplete before 2009 for Ontario. These data are presented as "not reported" Return to Table 10 footnote * referrer Table 10 footnote † All HIV cases in the blood/blood products exposure category were attributed to "recipient of blood" Return to table 10 first table 10 footnote † referrer Table 10 footnote ‡ For Alberta, cases identified as CIC/OOC were classified in the exposure category of "other" Return to table 10 first table 10 footnote ‡ referrer

Table 11: Number of HIV cases by exposure category and province/territory—Canada, 2015-2016^{Footnote *}
Year	Exposure category	Exposure sub-category	Province/territory													Total
Year	Exposure category	Exposure sub-category	BC	YT	AB	NT	NU	SK	MB	ON	QC^{Footnote †}	NB	NS	PE	NL	n	%^{Footnote ‡}
2016	MSM	n/a	133	0	87	DS	DS	7	24	362	NR	2	9	DS	6	633	44.0
	MSM/IDU	n/a	4	0	14	DS	DS	5	7	25	NR	0	0	DS	0	55	3.8
	IDU	n/a	15	0	27	DS	DS	97	3	70	NR	2	2	DS	0	216	15.0
	Blood/blood products^{Footnote §}	n/a	0	0	0	DS	DS	0	1	1	NR	0	0	DS	0	2	0.1
	Heterosexual contact	Origin from an HIV-endemic country	0	1	32	DS	DS	8	27	82	NR	3	0	DS	0	153	10.6
		Sexual contact with a person at risk	30	1	29	DS	DS	31	0	33	NR	0	1	DS	2	127	8.8
		NIR-Het	25	0	28	DS	DS	21	33	76	NR	0	2	DS	0	185	12.8
	Other	n/a	8	0	57	DS	DS	1	0	2	NR	0	0	DS	0	69	4.8
	2016 Subtotal	n/a	215	2	274	DS	DS	170	95	651	0	7	14	DS	8	1,440	100
	NIR	n/a	3	0	6	DS	DS	4	31	47	0	0	0	DS	0	91	n/a
	Not reported	n/a	35	0	2	DS	DS	0	0	183	593	0	0	DS	0	813	n/a
	2016 Grand Total	n/a	253	2	282	DS	DS	174	126	881	593	7	14	DS	8	2,344	n/a
2015	MSM	n/a	132	1	66	DS	DS	12	34	355	NR	3	12	DS	7	624	44.6
	MSM/IDU	n/a	4	0	8	DS	DS	2	3	26	NR	0	0	DS	0	43	3.1
	IDU	n/a	17	0	34	DS	DS	96	9	67	NR	0	1	DS	1	225	16.1
	Blood/blood products^{Footnote §}	n/a	0	0	0	DS	DS	0	0	1	NR	0	0	DS	0	1	0.1
	Heterosexual contact	Origin from an HIV-endemic country	0	0	29	DS	DS	5	22	92	NR	3	0	DS	0	151	10.8
		Sexual contact with a person at risk	39	0	32	DS	DS	22	0	21	NR	2	1	DS	1	119	8.5
		NIR-Het	30	0	17	DS	DS	20	27	77	NR	1	3	DS	2	177	12.6
		Other	5	0	47	DS	DS	6	0	1	NR	0	0	DS	0	60	4.3
	2015 Subtotal	n/a	227	1	233	DS	DS	163	95	640	0	9	17	DS	11	1,400	100
	NIR	n/a	3	0	2	DS	DS	2	10	42	0	0	0	DS	0	59	n/a
	Not reported	n/a	9	0	2	DS	DS	0	0	157	473	0	0	DS	0	641	n/a
	2015 Grand Total	n/a	239	1	237	DS	DS	165	105	839	473	9	17	DS	11	2,100	n/a
Table 11 footnotes Table 11 Abbreviations Abbreviations: BC, British Columbia; YT, Yukon; AB, Alberta; NT, Northwest Territories; NU, Nunavut; SK, Saskatchewan; MB, Manitoba; ON, Ontario; QC, Quebec; NB, New Brunswick; NS, Nova Scotia; PE, Prince Edward Island; NL, Newfoundland and Labrador; IDU, injection drug use; MSM, men who have sex with men; MSM/IDU, men who have sex with men and use injection drugs; n, number; n/a, not applicable; NIR, no identified risk; NIR-Het, no identified risk-heterosexual; NR, not reported to PHAC; DS, data supressed; %, percentage Table 11 footnote * Reporting of HIV cases for individuals younger than two years of age varies among provinces and territories Return to Table 11 footnote * referrer Table 11 footnote † For Quebec, the number of HIV cases is based on the minimum number of HIV-positive individuals Return to Table 11 footnote † referrer Table 11 footnote ‡ Percentages are based on the total number excluding "NIR" and "Not reported" Return to Table 11 footnote ‡ referrer Table 11 footnote § All HIV cases in the blood/blood products exposure category were attributed to "recipient of blood" Return to first Table 11 footnote § referrer

Table 12: Number and percentage distribution of HIV cases (all ages) by year of diagnosis and race/ethnicity—Canada, 1998-2016^{Footnote *} ^{Footnote †} ^{Footnote ‡}
Race/ethnicity	Race/ethnicity sub-category	Year of test												Total
		1998-2011		2012		2013		2014		2015		2016		n	%^{Footnote §}
		n	%	n	%	n	%	n	%	n	%	n	%	n	%^{Footnote §}
Indigenous	First Nations	1,401	19.8	174	15.9	131	12.6	142	13.9	167	15.4	217	19.0	2,232	17.9
	Métis	187	2.6	13	1.2	11	1.1	27	2.6	27	2.5	18	1.6	283	2.3
	Inuit	14	0.2	0	0.0	0	0.0	1	0.1	0	0.0	3	0.3	18	0.1
	Indigenous, unspecified	438	6.2	34	3.1	57	5.5	1	0.1	9	0.8	4	0.4	543	4.4
South Asian/West Asian/Arab^{Footnote ¶}	n/a	93	1.3	43	3.9	31	3.0	36	3.5	40	3.7	44	3.9	287	2.3
Asian^{Footnote ‖}	n/a	225	3.2	50	4.6	54	5.2	59	5.8	74	6.8	66	5.8	528	4.2
Black^{Footnote **}	n/a	1,243	17.6	285	26.1	208	19.9	237	23.1	225	20.8	250	21.9	2,448	19.7
Latin American^{Footnote ††}	n/a	170	2.4	37	3.4	57	5.5	55	5.4	48	4.4	55	4.8	422	3.4
White	n/a	3,241	45.8	437	40.0	479	45.9	441	43.0	470	43.5	460	40.4	5,528	44.4
Other	n/a	59	0.8	20	1.8	15	1.4	26	2.5	21	1.9	23	2.0	164	1.3
Subtotal	n/a	7,071	100	1,093	100	1,043	100	1,025	100	1,081	100	1,140	100	12,453	100
Not reported	n/a	25,897	n/a	980	n/a	1,017	n/a	1,028	n/a	1,019	n/a	1,204	n/a	31,145	n/a
Total	n/a	32,968	n/a	2,073	n/a	2,060	n/a	2,053	n/a	2,100	n/a	2,344	n/a	43,598	n/a
Table 12 footnotes Table 12 Abbreviations Abbreviations: n, number; n/a, not applicable; %, percentage Table 12 footnote * Consider data limitations regarding ethnicity/race information when interpreting these data Return to Table 12 footnote * referrer Table 12 footnote † For all provinces and territories, race/ethnicity information is not available before 1998. Race/ethnicity information is not submitted by Quebec or British Columbia, and is not available for Ontario before 2009 Return to Table 12 footnote † referrer Table 12 footnote ‡ Reporting of HIV cases for individuals younger than two years of age varies among provinces and territories Return to Table 12 footnote ‡ referrer Table 12 footnote § Percentages are based on the total number excluding "not reported" Return to Table 12 footnote § referrer Table 12 footnote ¶ For example, Pakistani, Sri Lankan, Bangladeshi, Armenian, Egyptian, Iranian, Lebanese and Moroccan Return to Table 12 footnote ¶ referrer Table 12 footnote ‖ For example, Chinese, Japanese, Vietnamese, Cambodian, Indonesian, Laotian, Korean and Filipino Return to Table 12 footnote ‖ referrer Table footnote For example, Somali, Haitian and Jamaican Return to Table 12 footnote ** referrer Table footnote For example, Mexican, Central American and South American Return to Table 12 footnote †† referrer

Table 13: Number and percentage distribution of HIV cases among males (all ages) by year of test and race/ethnicity—Canada, 1998-2016^{Footnote *} ^{Footnote †} ^{Footnote ‡}
Race/ethnicity	Race/ethnicity sub-category	Year of test												Total
		1998-2011		2012		2013		2014		2015		2016		n	%^{Footnote §}
		n	%	n	%	n	%	n	%	n	%	n	%	n	%^{Footnote §}
Indigenous	First Nations	689	14.1	106	13.4	74	9.3	76	9.9	91	11.5	113	13.7	1,149	13.0
	Métis	106	2.2	4	0.5	11	1.4	16	2.1	18	2.3	11	1.3	166	1.9
	Inuit	10	0.2	0	0.0	0	0.0	1	0.1	0	0.0	2	0.2	13	0.1
	Indigenous, unspecified	236	4.8	17	2.1	30	3.8	0	0.0	3	0.4	1	0.1	287	3.2
South Asian/West Asian/Arab^{Footnote ¶}	n/a	83	1.7	37	4.7	27	3.4	30	3.9	35	4.4	37	4.5	249	2.8
Asian^{Footnote ‖}	n/a	177	3.6	45	5.7	53	6.7	52	6.8	69	8.7	62	7.5	458	5.2
Black^{Footnote **}	n/a	605	12.4	142	17.9	103	12.9	137	17.9	104	13.1	135	16.4	1,226	13.8
Latin American^{Footnote ††}	n/a	152	3.1	36	4.5	53	6.7	50	6.5	43	5.4	52	6.3	386	4.4
White	n/a	2,784	57.0	390	49.1	431	54.1	382	49.8	411	51.8	394	47.8	4,792	54.1
Other	n/a	46	0.9	17	2.1	14	1.8	23	3.0	19	2.4	17	2.1	136	1.5
Subtotal	n/a	4,888	100	794	100	796	100	767	100	793	100	824	100	8,862	100
Not reported	n/a	19,644	n/a	790	n/a	807	n/a	781	n/a	796	n/a	964	n/a	23,782	n/a
Total^{Footnote ‡‡}	n/a	24,532	n/a	1,584	n/a	1,603	n/a	1,548	n/a	1,589	n/a	1,788	n/a	32,644	n/a
Table 13 footnotes Table 13 Abbreviations Abbreviations: n, number; n/a, not applicable; %, percentage Table 13 footnote * Consider data limitations regarding ethnicity/race information when interpreting these data Return to Table 13 footnote * referrer Table 13 footnote † For all provinces and territories, race/ethnicity information is not available before 1998. Race/ethnicity information is not submitted by Quebec or British Columbia, and is not available for Ontario before 2009 Return to Table 13 footnote † referrer Table 13 footnote ‡ Reporting of HIV cases for individuals younger than two years of age varies among provinces and territories Return to Table 13 footnote ‡ referrer Table 13 footnote § Percentages are based on the total number excluding "not reported" Return to Table 13 footnote § referrer Table 13 footnote ¶ For example, Pakistani, Sri Lankan, Bangladeshi, Armenian, Egyptian, Iranian, Lebanese and Moroccan Return to Table 13 footnote ¶ referrer Table 13 footnote ‖ For example, Chinese, Japanese, Vietnamese, Cambodian, Indonesian, Laotian, Korean and Filipino Return to Table 13 footnote ‖ referrer Table 13 footnote For example, Somali, Haitian and Jamaican Return to Table 13 footnote referrer Table 13 footnote †† For example, Mexican, Central American and South American Return to Table 13 footnote †† referrer Table 13 footnote ‡‡ Excludes 291 HIV cases where sex was not reported or reported as transsexual or transgender Return to Table 13 footnote ‡‡ referrer

Table 14: Number and percentage distribution of HIV cases among females (all ages) by year of diagnosis and race/ethnicity—Canada, 1998-2016^{Footnote *} ^{Footnote †} ^{Footnote ‡}
Race/ethnicity	Race/ethnicity sub-category	Year of test												Total
		1998-2011		2012		2013		2014		2015		2016		n	%^{Footnote §}
		n	%	n	%	n	%	n	%	n	%	n	%	n	%^{Footnote §}
Indigenous	First Nations	712	32.7	68	22.9	57	23.3	66	25.7	76	26.6	103	32.7	1,082	30.2
	Métis	81	3.7	9	3.0	0	0.0	11	4.3	9	3.1	7	2.2	117	3.3
	Inuit	4	0.2	0	0.0	0	0.0	0	0.0	0	0.0	1	0.3	5	0.1
	Indigenous, unspecified	202	9.3	17	5.7	27	11.0	1	0.4	6	2.1	3	1.0	256	7.2
South Asian/West Asian/Arab^{Footnote ‖}	n/a	10	0.5	6	2.0	4	1.6	6	2.3	5	1.7	7	2.2	38	1.1
Asian^{Footnote **}	n/a	48	2.2	5	1.7	1	0.4	7	2.7	4	1.4	4	1.3	69	1.9
Black^{Footnote ††}	n/a	637	29.2	143	48.1	104	42.4	100	38.9	121	42.3	115	36.5	1,220	34.1
Latin American^{Footnote ‡‡}	n/a	18	0.8	1	0.3	4	1.6	5	1.9	5	1.7	3	1.0	36	1.0
White	n/a	455	20.9	46	15.5	47	19.2	58	22.6	58	20.3	66	21.0	730	20.4
Other	n/a	13	0.6	2	0.7	1	0.4	3	1.2	2	0.7	6	1.9	27	0.8
Subtotal	n/a	2,180	100	297	100	245	100	257	100	286	100	315	100	3,580	100
Not reported	n/a	6,005	n/a	186	n/a	201	n/a	240	n/a	219	n/a	232	n/a	7,083	n/a
Total^{Footnote ¶¶}	n/a	8,185	n/a	483	n/a	446	n/a	497	n/a	505	n/a	547	n/a	10,663	n/a
Table 14 footnotes Table 14 Abbreviations Abbreviations: n, number; n/a, not applicable; %, percentage Table 14 footnote * Consider data limitations regarding ethnicity/race information when interpreting these data Return to Table 14 footnote * referrer Table 14 footnote † For all provinces and territories, race/ethnicity information is not available before 1998. Race/ethnicity information is not submitted by Quebec or British Columbia, and is not available for Ontario before 2009 Return to Table 14 footnote † referrer Table 14 footnote ‡ Reporting of HIV cases for individuals younger than two years of age varies among provinces and territories Return to Table 14 footnote ‡ referrer Table 14 footnote § Percentages are based on the total number excluding "not reported" Return to Table 14 footnote § referrer Table 14 footnote ‖ For example, Pakistani, Sri Lankan, Bangladeshi, Armenian, Egyptian, Iranian, Lebanese and Moroccan Return to Table 14 footnote ‖ referrer Table 14 footnote For example, Chinese, Japanese, Vietnamese, Cambodian, Indonesian, Laotian, Korean and Filipino Return to Table 14 footnote referrer Table 14 footnote †† For example, Somali, Haitian and Jamaican Return to Table 14 footnote †† referrer Table 14 footnote ‡‡ For example, Mexican, Central American and South American Return to Table 14 footnote ‡‡ referrer Table 14 footnote ¶¶ Excludes 291 HIV cases where sex was not reported or reported as transsexual or transgender Return to Table 14 footnote ¶¶ referrer

Table 15: Number of HIV cases (all ages) by exposure category and race/ethnicity—Canada, 1998-2016^{Footnote *} ^{Footnote †} ^{Footnote ‡} ^{Footnote §}
Year	Race/ethnicity	Race/ethnicity sub-category	MSM	MSM/IDU	IDU	Blood/blood products	Heterosexual contact			Perinatal trans-mission	Other	NIR	Not reported	Total
Year	Race/ethnicity	Race/ethnicity sub-category	MSM	MSM/IDU	IDU	Blood/blood products	Origin from an HIV-endemic country	Sexual contact with a person at risk	NIR-Het	Perinatal trans-mission	Other	NIR	Not reported	Total
2016	Indigenous	First Nations	18	12	96	1	0	35	48	0	0	7	0	217
		Métis	2	1	11	0	0	2	2	0	0	0	0	18
		Inuit	2	0	0	0	0	0	1	0	0	0	0	3
		Indigenous, unspecified	0	0	2	0	0	0	1	0	0	1	0	4
	South Asian/West Asian/Arab^{Footnote ‖}	n/a	31	0	0	0	1	3	5	0	3	1	0	44
	Asian^{Footnote **}	n/a	43	1	0	0	2	4	11	0	4	1	0	66
	Black^{Footnote ††}	n/a	43	2	3	1	133	7	18	0	41	1	1	250
	Latin American^{Footnote ‡‡}	n/a	43	2	0	0	1	3	3	0	2	1	0	55
	White	n/a	252	31	69	0	2	35	55	0	3	12	1	460
	Other	n/a	9	1	2	0	2	3	2	0	2	2	0	23
	Subtotal 2016	n/a	443	50	183	2	141	92	146	0	55	26	2	1,140
	Not reported	n/a	190	5	33	0	12	35	39	3	11	65	811	1,204
	Total 2016	n/a	633	55	216	2	153	127	185	3	66	91	813	2,344
2015	Indigenous	First Nations	8	2	94	0	0	30	24	3	3	2	1	167
		Métis	6	0	14	0	0	2	5	0	0	0	0	27
		Inuit	0	0	0	0	0	0	0	0	0	0	0	0
		Indigenous, unspecified	0	0	4	0	0	0	5	0	0	0	0	9
	South Asian/West Asian/Arab^{Footnote ‖}	n/a	21	0	5	0	1	3	9	0	0	1	0	40
	Asian^{Footnote **}	n/a	50	2	1	0	6	1	7	0	5	2	0	74
	Black^{Footnote ††}	n/a	36	4	0	1	127	6	16	0	33	1	1	225
	Latin American^{Footnote ‡‡}	n/a	26	1	2	0	1	2	10	0	4	2	0	48
	White	n/a	281	24	68	0	0	32	53	0	2	9	1	470
	Other	n/a	14	0	0	0	0	0	5	0	2	0	0	21
	Subtotal 2015	n/a	442	33	188	1	135	76	134	3	49	17	3	1,081
	Not reported	n/a	182	10	37	0	16	43	43	2	6	42	638	1,019
	Total 2015	n/a	624	43	225	1	151	119	177	5	55	59	641	2,100
2014	Indigenous	First Nations	10	5	69	0	0	27	23	0	4	3	1	142
		Métis	2	0	14	0	0	6	2	0	2	1	0	27
		Inuit	1	0	0	0	0	0	0	0	0	0	0	1
		Indigenous, unspecified	0	0	0	0	0	1	0	0	0	0	0	1
	South Asian/West Asian/Arab^{Footnote ‖}	n/a	16	0	1	0	3	5	9	0	0	2	0	36
	Asian^{Footnote **}	n/a	45	0	0	0	2	0	5	0	7	0	0	59
	Black^{Footnote ††}	n/a	48	3	3	1	115	10	5	0	50	2	0	237
	Latin American^{Footnote ‡‡}	n/a	36	3	1	0	2	2	6	0	3	2	0	55
	White	n/a	272	24	53	0	2	35	32	0	12	10	1	441
	Other	n/a	16	0	1	0	2	3	2	0	2	0	0	26
	Subtotal 2014	n/a	446	35	142	1	126	89	84	0	80	20	2	1,025
	Not reported	n/a	223	4	41	1	13	41	49	1	8	50	597	1,028
	Total 2014	n/a	669	39	183	2	139	130	133	1	88	70	599	2,053
2013	Indigenous	First Nations	7	2	72	0	0	27	16	0	3	3	1	131
		Métis	0	1	4	0	0	2	4	0	0	0	0	11
		Inuit	0	0	0	0	0	0	0	0	0	0	0	0
		Indigenous, unspecified	8	0	16	0	0	28	3	0	1	1	0	57
	South Asian/West Asian/Arab^{Footnote ‖}	n/a	19	1	0	0	0	4	5	0	0	2	0	31
	Asian^{Footnote **}	n/a	46	2	0	0	2	3	0	0	1	0	0	54
	Black^{Footnote ††}	n/a	33	0	3	0	105	6	11	1	49	0	0	208
	Latin American^{Footnote ‡‡}	n/a	46	0	0	0	1	4	3	0	2	1	0	57
	White	n/a	308	22	51	0	2	42	40	0	8	6	0	479
	Other	n/a	8	1	1	0	0	1	2	0	2	0	0	15
	Subtotal 2013	n/a	475	29	147	0	110	117	84	1	66	13	1	1,043
	Not reported	n/a	200	9	39	1	20	42	52	4	9	25	616	1,017
	Total 2013	n/a	675	38	186	1	130	159	136	5	75	38	617	2,060
2012	Indigenous	First Nations	11	3	104	0	0	27	21	0	5	3	0	174
		Métis	2	0	9	0	0	1	1	0	0	0	0	13
		Inuit	0	0	0	0	0	0	0	0	0	0	0	0
		Indigenous, unspecified	3	1	9	0	0	20	0	0	0	1	0	34
	South Asian/West Asian/Arab^{Footnote ‖}	n/a	19	1	1	0	1	5	10	1	0	5	0	43
	Asian^{Footnote **}	n/a	36	0	0	0	1	6	5	0	1	1	0	50
	Black^{Footnote ††}	n/a	50	3	3	0	160	11	12	0	44	2	0	285
	Latin American^{Footnote ‡‡}	n/a	29	1	0	0	0	0	2	0	3	2	0	37
	White	n/a	290	13	45	0	1	37	37	0	4	10	0	437
	Other	n/a	13	0	0	0	2	0	2	0	0	3	0	20
	Subtotal 2012	n/a	453	22	171	0	165	107	90	1	57	27	0	1,093
	Not reported	n/a	212	8	45	0	9	38	43	0	7	37	581	980
	Total 2012	n/a	665	30	216	0	174	145	133	1	64	64	581	2,073
1998 - 2011	Indigenous	First Nations	46	37	905	2	2	211	143	11	5	20	19	1,401
		Métis	10	9	125	1	0	22	14	1	0	3	2	187
		Inuit	3	0	3	0	1	2	5	0	0	0	0	14
		Indigenous, unspecified	33	9	149	7	0	202	5	1	1	31	0	438
	South Asian/West Asian/Arab^{Footnote ‖}	n/a	49	1	1	2	7	12	11	0	0	10	0	93
	Asian^{Footnote **}	n/a	119	4	2	0	25	26	42	0	3	4	0	225
	Black^{Footnote ††}	n/a	113	3	26	3	933	46	51	6	45	11	6	1,243
	Latin American^{Footnote ‡‡}	n/a	123	1	2	1	8	15	14	0	3	2	1	170
	White	n/a	1,669	102	608	17	14	397	318	5	21	70	20	3,241
	Other	n/a	27	0	10	0	5	4	9	1	2	0	1	59
	Subtotal 1998-2011	n/a	2,192	166	1,831	33	995	937	1,836	25	80	151	49	7,071
	Not reported	n/a	6,423	394	2,416	55	1,618	1,141	1,836	98	71	946	10,899	25,897
	Total 1998-2011	n/a	8,615	560	4,247	88	2,613	2,078	3,672	123	151	1,097	10,948	32,968
Total all years		n/a	11,881	765	5,273	94	3,360	2,758	4,436	138	499	1,419	14,199	43,598
Table 15 footnotes Table 15 Abbreviations Abbreviations: IDU, injection drug use; MSM, Men who have sex with men; MSM/IDU, men who have sex with men and use injection drugs; NIR, no identified risk; NIR-Het, no identified risk-heterosexual Table 15 footnote * Consider data limitations regarding ethnicity/race information when interpreting these data Return to Table 15 footnote* referrer Table 15 footnote † For all provinces and territories, race/ethnicity information is not available before 1998. Race/ethnicity information is not submitted by Quebec or British Columbia, and is not available for Ontario before 2009 Return to Table 15 footnote† referrer Table 15 footnote ‡ Exposure category data are not available for Quebec and are incomplete before 2009 for Ontario. These data are presented as "not reported" Return to Table 15 footnote‡ referrer Table 15 footnote § Reporting of HIV cases for individuals younger than two years of age varies among provinces and territories Return to Table 15 footnote§ referrer Table 15 footnote ‖ For example, Pakistani, Sri Lankan, Bangladeshi, Armenian, Egyptian, Iranian, Lebanese and Moroccan Return to first Table 15 footnote‖ referrer Table footnote For example, Chinese, Japanese, Vietnamese, Cambodian, Indonesian, Laotian, Korean and Filipino Return to first Table 15 footnote** referrer Table footnote For example, Somali, Haitian and Jamaican Return to first Table 15 footnote†† referrer Table footnote For example, Mexican, Central American and South American Return to first Table 15 footnote‡‡ referrer

Table 16: Number and percentage distribution of immigration applicants to Canada diagnosed with HIV as a result of an Immigration Medical Exam (IME) by year—2002-2016
Year^{Footnote †}	Tested in Canada^{Footnote *}		Tested overseas
Year^{Footnote †}	Number diagnosed with HIV	%	Number diagnosed with HIV	%
2002	265	n/a	NR	n/a
2003	366	n/a	NR	n/a
2004	329	n/a	NR	n/a
2005	282	65.4	149	34.6
2006	373	69.9	161	30.1
2007	308	73.5	111	26.5
2008	365	66.6	183	33.4
2009	275	76.6	84	23.4
2010	231	67.5	111	32.5
2011	210	63.8	119	36.2
2012	243	63.4	140	36.6
2013	422	67.7	201	32.3
2014	345	67.9	163	32.1
2015	350	63.6	200	36.4
Total	4,364	72.9	1,622	27.1
Table 16 footnotes Table 16 Abbreviations Abbreviations: n/a, not applicable; %, percentage Table 16 footnote * Immigration, Refugees, and Citizenship Canada, IRCC GCMS and IMS/FOSS as of July 2017. Reproduced and distributed with the permission of Immigration, Refugees, and Citizenship Canada Return to Table 16 footnote * referrer Table 16 footnote † For applicants tested in Canada, the year refers to the year of the test. For applicants tested overseas, the year refers to the year the applicant landed in Canada Return to Table 16 footnote † referrer

Table 17: Number and percentage distribution of immigration applicants to Canada diagnosed with HIV as a result of an Immigration Medical Exam (IME) by sex, age group, and province—2002-2016
Demographic	Tested in Canada^{Footnote *}		Tested overseas^{Footnote *}
Demographic	Number diagnosed with HIV	%	Number diagnosed with HIV	%
Sex
Male	2,493	57.1	788	48.6
Female	1,870	42.9	834	51.4
Age group
<20	79	1.8	141	8.7
20-29	970	22.2	411	25.3
30-39	1,829	41.9	649	40.0
40-49	1,090	25.0	311	19.2
50+	396	9.1	110	6.8
Province^{Footnote †}
Alberta	330	7.6	232	14.4
British Columbia	380	8.7	209	12.9
Manitoba	90	2.1	140	8.7
Ontario	2,386	54.7	540	33.4
Quebec	1,098	25.2	404	25.0
Saskatchewan	42	1.0	46	2.8
Atlantic provinces^{Footnote ‡}	37	0.8	45	2.8
HIV-endemic country
Yes	2,937	67.3	1,170	72.1
No	1,427	32.7	452	27.9
Table 17 footnotes Table 17 Abbreviations Abbreviation: %, percentage Table 17 footnote * Immigration, Refugees, and Citizenship Canada, IRCC GCMS and IMS/FOSS as of July 2017. Reproduced and distributed with the permission of Immigration, Refugees, and Citizenship Canada Return to first Table 17 footnote * referrer Table 17 footnote † For applicants tested in Canada, the province refers to the province where the test was conducted. For applicants tested overseas, the province refers the intended province of residence Return to Table 17 footnote † referrer Table 17 footnote ‡ Due to small numbers, the data for the Atlantic provinces (New Brunswick, Newfoundland and Labrador, Nova Scotia and Prince Edwards Island) are aggregated Return to Table 17 footnote ‡ referrer

Table 18: Number of Canadian perinatally HIV-exposed infants by year of birth, current status and use of antiretroviral therapy (ART) for prophylaxis, 1984-2016
ART use	Status	Year of birth									Total
ART use	Status	1984-2008	2009	2010	2011	2012	2013	2014	2015	2016	Total
No perinatal ART prophylaxis	Confirmed infected
	Asymptomatic	74	6	6	5	1	2	0	2	1	97
	Symptomatic	22	0	1	0	0	0	0	1	0	24
	Died of AIDS	100	0	0	0	0	0	0	0	0	100
	Died of other	10	0	0	0	0	0	0	0	0	10
	Lost to follow-up^{Footnote *}	170	3	1	0	0	1	0	2	0	177
	Adult care^{Footnote †}	216	0	0	0	0	0	0	0	0	216
	Subtotal confirmed infected	592	9	8	5	1	3	0	5	1	624
	Subtotal confirmed not infected	481	17	11	7	9	5	7	6	8	551
	Infection status not confirmed
	Indeterminate	0	0	0	0	0	0	0	0	1	1
	Lost to follow-up	23	0	0	1	1	0	0	0	0	25
	Subtotal Infection status not confirmed	23	0	0	1	1	0	0	0	1	26
	Total ‘No perinatal ART prophylaxis’	1,096	26	19	13	11	8	7	11	10	1,201
Any perinatal ART prophylaxis	Confirmed infected
	Asymptomatic	2	0	3	2	0	0	2	1	0	10
	Symptomatic	2	0	0	1	0	0	0	0	0	3
	Died of AIDS	1	0	0	0	0	0	0	0	0	1
	Died of other	1	0	0	0	0	0	0	0	0	1
	Lost to follow-up^{Footnote *}	9	1	1	0	0	0	0	0	0	11
	Adult care^{Footnote †}	5	0	0	0	0	0	0	0	0	5
	Subtotal confirmed infected	20	1	4	3	0	0	2	1	0	31
	Subtotal confirmed not infected	1,789	172	222	216	216	198	238	230	226	3,507
	Infection status not confirmed
	Indeterminate	0	0	0	0	0	0	0	0	24	24
	Lost to follow-up	22	1	1	1	1	0	0	4	1	31
	Subtotal Infection status not confirmed	22	1	1	1	1	0	0	4	25	55
	Total ‘Any perinatal ART prophylaxis	1,831	174	227	220	217	198	240	235	251	3,593
Perinatal ART prophylaxis exposure unknown	Total ‘Perinatal ART prophylaxis exposure unknown’	35	3	4	4	1	2	2	2	2	55
Grand Total		2,962	203	250	237	229	208	249	248	263	4,849
Table 18 footnotes Table 18 Abbreviations Abbreviation: ART, antiretroviral therapy Table 18 footnote * A child is considered to be lost to follow-up if there are no current status data for the past three years or for the three years before the child turned 18 years old Return to first Table 18 footnote * referrer Table 18 footnote † These are subjects that were 18 years of age or over by the end of 2016 and transferred to adult care Return to first Table 18 footnote † referrer

Table 19: Number of Canadian perinatally HIV-exposed infants by maternal exposure category and year of infant birth, 1984-2016
Maternal exposure category	Year of birth
	1984-2008		2009		2010		2011		2012		2013		2014		2015		2016		Total
	n	%	n	%	n	%	n	%	n	%	n	%	n	%	n	%	n	%	n	%^{Footnote *}
IDU	660	24.6	31	16.8	43	19.2	47	21.2	34	16.6	34	18.0	48	20.7	54	23.9	50	22.3	1,001	22.8
Blood products/ transfusion/ medical	44	1.6	5	2.7	5	2.2	1	0.5	3	1.5	8	4.2	5	2.2	5	2.2	2	0.9	78	1.8
Heterosexual contact	1,962	73.0	144	78.3	173	77.2	174	78.4	165	80.5	143	75.7	167	72.0	153	67.7	159	71.0	3,240	73.8
Mother-to-child^{Footnote †}	6	0.2	3	1.6	3	1.3	0	0.0	3	1.5	3	1.6	6	2.6	12	5.3	8	3.6	44	1.0
Other	15	0.6	1	0.5	0	0.0	0	0.0	0	0.0	1	0.5	6	2.6	2	0.9	5	2.2	30	0.7
NIR	275	n/a	19	n/a	26	n/a	15	n/a	24	n/a	19	n/a	17	n/a	22	n/a	39	n/a	456	n/a
Total	2,962	100	203	100	250	100	237	1	229	100	208	100	249	100	248	100	263	100	4,849	100
Table 19 footnotes Table 19 Abbreviations Abbreviations: IDU, injection drug user; n, number; n/a, not applicable; NIR, no identified risk; %, percentage Table 19 footnote * Percentages based on total number minus reports for which there was no identified risk (NIR) Return to Table 19 footnote * referrer Table 19 footnote † This category includes infants whose mothers contracted HIV at birth from their own mothers Return to Table 19 footnote † referrer

Table 20: Number of Canadian perinatally HIV-exposed infants by ethnic status and infection status, 1984-2016
Race/ethnicity	Infection Status	Year of birth																				Total
		1984-1996		1997-2008		2009		2010		2011		2012		2013		2014		2015		2016		Total
		n	%	n	%	n	%	n	%	n	%	n	%	n	%	n	%	n	%	n	%	n	%
White	Prospective cohort^{Footnote *}
	Confirmed infected	29	16.4	9	1.8	0	0.0	4	8.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	42	4.2
	Confirmed not infected	148	83.6	485	98.2	29	100	46	92.0	36	100	39	100.0	37	100	60	100	48	100	27	100	955	95.8
	Retrospective cohort
	Confirmed infected	76	69.7	9	50.0	2	100	0	0.0	1	50.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	88	66.7
	Confirmed not infected	33	30.3	9	50.0	0	0.0	1	100	1	50.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	44	33.3
	Infection status not confirmed
	Infection status not confirmed	9	n/a	8	n/a	1	n/a	0	n/a	0	n/a	1	n/a	0	n/a	0	n/a	1	n/a	4	n/a	24	n/a
	Subtotal White	295	36.7	520	24.1	32	15.8	51	20.4	38	16.0	40	17.5	37	17.8	60	24.1	49	19.8	31	11.8	1,153	23.8
Black^{Footnote ‡}	Prospective cohort
	Confirmed infected	32	21.3	21	2.4	1	0.9	0	0.0	3	2.5	0	0.0	0	0.0	1	0.8	0	0.0	0	0.0	58	2.9
	Confirmed not infected	118	78.7	848	97.6	107	99.1	119	100	118	97.5	136	100.0	107	100	126	99.2	111	100	119	100.0	1,909	97.1
	Retrospective cohort
	Confirmed infected	170	85.4	165	81.3	3	75.0	4	100	3	100	1	33.3	2	100	0	0.0	1	100	1	50.0	350	83.1
	Confirmed not infected	29	14.6	38	18.7	1	25.0	0	0.0	0	0.0	2	66.7	0	0.0	0	0.0	0	0.0	1	50.0	71	16.9
	Infection status not confirmed
	Infection status not confirmed	7	n/a	6	n/a	1	n/a	0	n/a	2	n/a	0	n/a	0	n/a	0	n/a	2	n/a	7	n/a	25	n/a
	Subtotal Black	356	44.3	1078	50.0	113	55.7	123	49.2	126	53.2	139	60.7	109	52.4	127	51.0	114	46.0	128	48.7	2,413	49.8
Latin American^{Footnote §}	Prospective cohort
	Confirmed infected	5	71.4	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	5	10.6
	Confirmed not infected	2	28.6	17	100	5	100	0	0.0	5	100	3	100.0	0	0.0	1	100.0	5	100.0	4	100	42	89.4
	Retrospective cohort
	Confirmed infected	4	100.0	1	50.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	5	83.3
	Confirmed not infected	0	0.0	1	50.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	1	16.7
	Infection status not confirmed
	Infection status not confirmed	0	n/a	3	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	3	n/a
	Subtotal Latin American	11	1.4	22	1.0	5	2.5	0	0.0	5	2.1	3	1.3	0	0.0	1	0.4	5	2.0	4	1.5	56	1.2
Aboriginal^{Footnote ¶}	Prospective cohort
	Confirmed infected	11	21.6	17	4.6	0	0.0	2	4.0	0	0.0	0	0.0	1	2.0	0	0.0	5	8.5	0	0.0	36	4.5
	Confirmed not infected	40	78.4	351	95.4	37	100	48	96.0	49	100	35	100	50	98.0	47	100	54	91.5	56	100	767	95.5
	Retrospective cohort
	Confirmed infected	14	63.6	6	46.2	1	33.3	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	21	55.3
	Confirmed not infected	8	36.4	7	53.8	2	66.7	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	17	44.7
	Infection status not confirmed
	Infection status not confirmed	3	n/a	6	n/a	0	n/a	0	n/a	0	n/a	1	n/a	0	n/a	0	n/a	1	n/a	11	n/a	22	n/a
	Subtotal Aboriginal	76	9.5	387	17.9	40	19.7	50	20.0	49	20.7	36	15.7	51	24.5	47	18.9	60	24.2	67	25.5	863	17.8
Asian^{Footnote ‖}	Prospective cohort
	Confirmed infected	0	0.0	2	3.3	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	2	1.6
	Confirmed not infected	7	100	58	96.7	6	100	9	100	6	100	6	100	5	100.0	6	100	8	100	13	100	124	98.4
	Retrospective cohort
	Confirmed infected	15	88.2	12	75.0	3	100.0	4	100.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	34	79.1
	Confirmed not infected	2	11.8	4	25.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	2	100.0	1	100.0	0	0.0	9	20.9
	Infection status not confirmed
	Infection status not confirmed	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a
	Subtotal Asian	24	3.0	76	3.5	9	4.4	13	5.2	6	2.5	6	2.6	5	2.4	8	3.2	9	3.6	13	4.9	169	3.5
Other^{Footnote **}	Prospective cohort
	Confirmed infected	1	25.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	1	1.4
	Confirmed not infected	3	75.0	25	100.0	1	100.0	6	100.0	8	100.0	5	100.0	5	100.0	4	100.0	4	100.0	7	100.0	68	98.6
	Retrospective cohort
	Confirmed infected	3	50.0	3	60.0	0	0.0	1	100.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	7	58.3
	Confirmed not infected	3	50.0	2	40.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	5	41.7
	Infection status not confirmed
	Infection status not confirmed	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a
	Subtotal Other	10	1.2	30	1.4	1	0.5	7	2.8	8	3.4	5	2.2	5	2.4	4	1.6	4	1.6	7	2.7	81	1.7
Unknown	Prospective cohort
	Confirmed infected	1	100.0	2	7.1	1	50.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	4	7.1
	Confirmed not infected	0	0.0	26	92.9	1	50.0	5	100.0	3	100.0	0	0.0	0	0.0	1	100.0	7	100.0	9	100.0	52	92.9
	Retrospective cohort
	Confirmed infected	10	33.3	15	100.0	1	100.0	0	0.0	2	100.0	0	0.0	0	0.0	1	100.0	0	0.0	0	0.0	29	58.0
	Confirmed not infected	20	66.7	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	1	100.0	0	0.0	0	0.0	0	0.0	21	42.0
	Infection status not confirmed
	Infection status not confirmed	1	n/a	2	n/a	0	n/a	1	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	4	n/a	8	n/a
	Subtotal Unknown	32	4.0	45	2.1	3	1.5	6	2.4	5	2.1	0	0.0	1	0.5	2	0.8	7	2.8	13	4.9	114	2.4
Total ethnicities	Prospective cohort
	Confirmed infected	79	19.9	51	2.7	2	1.1	6	2.5	3	1.3	0	0.0	1	0.5	1	0.4	5	2.1	0	0.0	148	3.6
	Confirmed not infected	318	80.1	1,810	97.3	186	98.9	233	97.5	225	98.7	224	100.0	204	99.5	245	99.6	237	97.9	235	100.0	3,917	96.4
	Retrospective cohort
	Confirmed infected	292	75.5	211	77.6	10	76.9	9	90.0	6	85.7	1	33.3	2	66.7	1	33.3	1	50.0	1	50.0	534	76.1
	Confirmed not infected	95	24.5	61	22.4	3	23.1	1	10.0	1	14.3	2	66.7	1	33.3	2	66.7	1	50.0	1	50.0	168	23.9
	Infection status not confirmed
	Infection status not confirmed	20	n/a	25	n/a	2	n/a	1	n/a	2	n/a	2	n/a	0	n/a	0	n/a	4	n/a	26	n/a	82	n/a
	Grand total	804	100.0	2,158	100.0	203	100.0	250	100.0	237	100.0	229	100.0	208	100.0	249	100.0	248	100.0	263	100.0	4,849	100.0
Table 20 footnotes Table 20 Abbreviations Abbreviations: n, number; n/a, not applicable; %, percentage Table 20 footnote * The prospective cohort consists of children born in Canada and identified before birth or within three months of birth. The retrospective cohort consists of children identified three months after birth or children born abroad Return to Table 20 footnote * referrer Table 20 footnote ‡ For example, African, Somali, Haitian and Jamaican Return to Table 20 footnote ‡ referrer Table 20 footnote § For example, Mexican and Central/South American Return to Table 20 footnote § referrer Table 20 footnote ¶ Includes Inuit, Métis, First Nations and Aboriginal unspecified Return to Table 20 footnote ¶ referrer Table 20 footnote ‖ For example, Chinese, Japanese, Vietnamese, Cambodian, Indonesian, Laotian, Korean, Filipino and Lebanese Return to Table 20 footnote ‖ referrer Table footnote "Other" includes cases designated as Arab/West Asian Return to Table 20 footnote ** referrer Note: The HIV status of infants is reported as "confirmed infected," "confirmed not infected," or "infection status not confirmed," according to the United States Centers for Disease Control and Prevention (CDC) surveillance case definitions for HIV infection. Tests for HIV deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) (polymerase chain reaction) are used to confirm infection status by four months of age. Infants are classified as "not confirmed" if they have not yet received the required number of tests to determine their HIV status. The current status of confirmed infected infants is defined as "asymptomatic," "symptomatic," "died of AIDS," "died of a cause other than AIDS" or "lost to follow-up"

Table 21: Number of Canadian perinatally HIV-exposed infants by maternal country of birth and infection status, 1984-2016
Country of birth	Infection status	Year of birth																				Total
		1984-1996		1997-2008		2009		2010		2011		2012		2013		2014		2015		2016		Total
		n	%	n	%	n	%	n	%	n	%	n	%	n	%	n	%	n	%	n	%	n	%
North America	*Prospective cohort^{Footnote }**
	Confirmed infected	41	17.4	25	2.8	1	1.5	6	5.6	0	0.0	0	0.0	1	1.1	0	0.0	5	4.5	0	0.0	79	4.2
	Confirmed not infected	195	82.6	867	97.2	67	98.5	102	94.4	90	100.0	74	100.0	89	98.9	107	100.0	105	95.5	88	100.0	1,784	95.8
	Retrospective cohort
	Confirmed infected	73	67.0	15	48.4	2	50.0	0	0.0	1	50.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	91	62.3
	Confirmed not infected	36	33.0	16	51.6	2	50.0	0	0.0	1	50.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	55	37.7
	Infection status not confirmed
	Infection status not confirmed	10	n/a	14	n/a	1	n/a	1	n/a	0	n/a	2	n/a	0	n/a	0	n/a	2	n/a	15	n/a	45	n/a
	Subtotal North America	355	44.2	937	43.4	73	36.0	109	43.6	92	38.8	76	33.2	90	43.3	107	43.0	112	45.2	103	39.2	2,054	42.4
Africa	Prospective cohort
	Confirmed infected	11	22.4	16	2.4	0	0.0	0	0.0	2	1.9	0	0.0	0	0.0	1	1.0	0	0.0	0	0.0	30	2.0
	Confirmed not infected	38	77.6	657	97.6	89	100.0	99	100.0	101	98.1	112	100.0	95	100.0	100	99.0	95	100.0	106	100.0	1,492	98.0
	Retrospective cohort
	Confirmed infected	112	88.2	139	80.3	3	75.0	2	100.0	1	100.0	1	100.0	1	100.0	0	0.0	1	100.0	1	50.0	261	83.7
	Confirmed not infected	15	11.8	34	19.7	1	25.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	1	50.0	51	16.3
	Infection status not confirmed
	Infection status not confirmed	3	n/a	5	n/a	0	n/a	0	n/a	2	n/a	0	n/a	0	n/a	0	n/a	2	n/a	7	n/a	19	n/a
	Subtotal Africa	179	22.3	851	39.4	93	45.8	101	40.4	106	44.7	113	49.3	96	46.2	101	40.6	98	39.5	115	43.7	1,853	38.2
Caribbean	Prospective cohort
	Confirmed infected	21	24.1	5	3.0	1	8.3	0	0.0	1	7.7	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	28	7.7
	Confirmed not infected	66	75.9	162	97.0	11	91.7	15	100.0	12	92.3	15	100.0	11	100.0	19	100.0	11	100.0	12	100.0	334	92.3
	Retrospective cohort
	Confirmed infected	60	78.9	21	77.8	0	0.0	1	100.0	1	100.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	83	78.3
	Confirmed not infected	16	21.1	6	22.2	0	0.0	0	0.0	0	0.0	1	100.0	0	0.0	0	0.0	0	0.0	0	0.0	23	21.7
	Infection status not confirmed
	Infection status not confirmed	4	n/a	1	n/a	1	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	6	n/a
	Subtotal Caribbean	167	20.8	195	9.0	13	6.4	16	6.4	14	5.9	16	7.0	11	5.3	19	7.6	11	4.4	12	4.6	474	9.8
Central and South America	Prospective cohort
	Confirmed infected	4	44.4	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	4	6.6
	Confirmed not infected	5	55.6	27	100.0	6	100.0	0	0.0	5	100.0	4	100.0	0	0.0	2	100.0	4	100.0	4	100.0	57	93.4
	Retrospective cohort
	Confirmed infected	9	100.0	2	100.0	0	0.0	1	100.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	12	100.0
	Confirmed not infected	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0
	Infection status not confirmed
	Infection status not confirmed	0	n/a	2	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	2	n/a
	Subtotal Central and South America	18	2.2	31	1.4	6	3.0	1	0.4	5	2.1	4	1.7	0	0.0	2	0.8	4	1.6	4	1.5	75	1.5
Asia	Prospective cohort
	Confirmed infected	0	0.0	2	3.3	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	2	1.5
	Confirmed not infected	6	100.0	58	96.7	6	100.0	9	100.0	9	100.0	6	100.0	4	100.0	8	100.0	9	100.0	13	100.0	128	98.5
	Retrospective cohort
	Confirmed infected	12	100.0	13	86.7	3	100.0	4	100.0	2	100.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	34	87.2
	Confirmed not infected	0	0.0	2	13.3	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	2	100.0	1	100.0	0	0.0	5	12.8
	Infection status not confirmed
	Infection status not confirmed	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a
	Subtotal Asia	18	2.2	75	3.5	9	4.4	13	5.2	11	4.6	6	2.6	4	1.9	10	4.0	10	4.0	13	4.9	169	3.5
Europe	Prospective cohort
	Confirmed infected	1	16.7	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	1	2.2
	Confirmed not infected	5	83.3	11	100.0	1	100.0	6	100.0	1	100.0	5	100.0	2	100.0	5	100.0	6	100.0	3	100.0	45	97.8
	Retrospective cohort
	Confirmed infected	15	78.9	3	100.0	1	100.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	19	79.2
	Confirmed not infected	4	21.1	0	0.0	0	0.0	1	100.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	5	20.8
	Infection status not confirmed
	Infection status not confirmed	1	n/a	1	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	2	n/a
	Subtotal Europe	26	3.2	15	0.7	2	1.0	7	2.8	1	0.4	5	2.2	2	1.0	5	2.0	6	2.4	3	1.1	72	1.5
Unknown	Prospective cohort
	Confirmed infected	1	25.0	3	9.7	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	4	4.9
	Confirmed not infected	3	75.0	28	90.3	6	100.0	2	100.0	7	100.0	8	100.0	3	100.0	4	100.0	7	100.0	9	100.0	77	95.1
	Retrospective cohort
	Confirmed infected	11	31.4	18	85.7	1	100.0	1	100.0	1	100.0	0	0.0	1	50.0	1	100.0	0	0.0	0	0.0	34	54.0
	Confirmed not infected	24	68.6	3	14.3	0	0.0	0	0.0	0	0.0	1	100.0	1	50.0	0	0.0	0	0.0	0	0.0	29	46.0
	Infection status not confirmed
	Infection status not confirmed	2	n/a	2	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	0	n/a	4	n/a	8	n/a
	Subtotal Unknown	41	5.1	54	2.5	7	3.4	3	1.2	8	3.4	9	3.9	5	2.4	5	2.0	7	2.8	13	4.9	152	3.1
Total	Prospective cohort
	Confirmed infected	79	19.9	51	2.7	2	1.1	6	2.5	3	1.3	0	0.0	1	0.5	1	0.4	5	2.1	0	0.0	148	3.6
	Confirmed not infected	318	80.1	1,810	97.3	186	98.9	233	97.5	225	98.7	224	100.0	204	99.5	245	99.6	237	97.9	235	100.0	3,917	96.4
	Retrospective cohort
	Confirmed infected	292	75.5	211	77.6	10	76.9	9	90.0	6	85.7	1	33.3	2	66.7	1	33.3	1	50.0	1	50.0	534	76.1
	Confirmed not infected	95	24.5	61	22.4	3	23.1	1	10.0	1	14.3	2	66.7	1	33.3	2	66.7	1	50.0	1	50.0	168	23.9
	Infection status not confirmed
	Infection status not confirmed	20	n/a	25	n/a	2	n/a	1	n/a	2	n/a	2	n/a	0	n/a	0	n/a	4	n/a	26	n/a	82	n/a
	Grand Total	804	100.0	2,158	100.0	203	100.0	250	100.0	237	100.0	229	100.0	208	100.0	249	100.0	248	100.0	263	100.0	4,849	100.0
Table 21 footnotes Table 21 Abbreviations Abbreviations: n, number; n/a, not applicable; %, percentage Table 21 footnote * The prospective cohort consists of children born in Canada and identified before birth or within three months of birth. The retrospective cohort consists of children identified three months after birth or children born abroad Return to Table 21 footnote * referrer Note: The HIV status of infants is reported as "confirmed infected," "confirmed not infected," or "infection status not confirmed," according to the United States Centers for Disease Control and Prevention (CDC) surveillance case definitions for HIV infection^{Footnote 2}. Tests for HIV deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) (polymerase chain reaction) are used to confirm infection status by four months of age. Infants are classified as "not confirmed" if they have not yet received the required number of tests to determine their HIV status. The current status of confirmed infected infants is defined as "asymptomatic," "symptomatic," "died of AIDS," "died of a cause other than AIDS" or "lost to follow-up"

Table 22: Number of Canadian perinatally HIV-exposed infants by geographic region and status at last report, 1984-2016
Province	Confirmed infected							Confirmed not infected	Infection status not confirmed			Total
Province	Asymptomatic	Symptomatic	Died of AIDS	Died of other	LFU	Adult care	Subtotal	Confirmed not infected	In-determinate	LFU	Subtotal	n	%
British Columbia	17	4	4	2	4	39	70	553	3	6	9	632	13.0
Alberta	20	1	5	1	20	22	69	590	11	12	23	682	14.1
Saskatchewan	17	1	1	0	2	4	25	271	5	2	7	303	6.2
Manitoba	0	0	1	0	5	2	8	246	2	2	4	258	5.3
Ontario	31	16	40	6	118	61	272	1,388	3	13	16	1,676	34.6
Quebec	34	10	44	1	41	94	224	1,000	0	21	21	1,245	25.7
Atlantic	1	0	5	1	2	4	13	36	0	1	1	50	1.0
Yukon/Northwest Territories	0	0	1	0	0	0	1	1	1	0	1	3	0.1
Total	120	32	101	11	192	226	682	4,085	25	57	82	4,849	100.0
% of subtotal	17.6	4.7	14.8	1.6	28.2	33.1	100.0	100.0	30.5	69.5	100.0	n/a	n/a
% of total	2.5	0.7	2.1	0.2	4.0	4.7	14.1	84.2	0.5	1.2	1.7	n/a	n/a
Table 22 footnotes Table 22 Abbreviations Abbreviations: BC, British Columbia; LFU, lost to follow-up; n, number; n/a, not applicable; NWT, Northwest Territories; %, percentage Note: The HIV status of infants is reported as "confirmed infected," "confirmed not infected," or "infection status not confirmed," according to the United States Centers for Disease Control and Prevention (CDC) surveillance case definitions for HIV infection^{Footnote 2}. Tests for HIV deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) (polymerase chain reaction) are used to confirm infection status by four months of age. Infants are classified as "not confirmed" if they have not yet received the required number of tests to determine their HIV status. The current status of confirmed infected infants is defined as "asymptomatic," "symptomatic," "died of AIDS," "died of a cause other than AIDS" or "lost to follow-up".

Table 23: International statistics on reported HIV cases, 2015
Continent	Country	Cumulative number to 2015^{Footnote *}	Number reported in 2015	All ages rate per 100,000 population for 2015
North America and Australia	Canada	77,806	2,100	5.8
	United States (2014 data)^{Footnote †}	NR	40,234	12.6
	United States^{Footnote †}	NR	39,513	12.3
	Australia^{Footnote ‡}	36,171	1,025	4.4
Western Europe^{Footnote §}	Austria	8,805	264	3.1
	Andorra	78	4	5.7
	Belgium	28,909	1,001	8.9
	Denmark	7,105	277	4.9
	Finland	3,573	174	3.2
	France	71,261	3,943	5.9
	Germany	57,251	3,674	4.5
	Greece	15,220	691	6.4
	Iceland	333	12	3.6
	Ireland	7,835	486	10.5
	Israel	8,896	428	5.3
	Italy	37,023	3,444	5.7
	Luxembourg	1,443	57	10.1
	Malta	324	61	14.2
	Netherlands	24,085	802	4.7
	Norway	5,858	221	4.3
	Portugal	54,297	990	9.5
	San Marino	87	2	6.3
	Spain	39,352	3,428	7.4
	Sweden	12,199	447	4.6
	Switzerland	35,001	537	6.5
	United Kingdom	145,552	6,078	9.4
Table 23 footnotes Table 23 Abbreviations Abbreviation: NR, Not reported Table 23 footnote * The cumulative number is the total number of cases reported by each country since reporting began Return to Table 23 footnote * referrer Table 23 footnote † Centers for Disease Control and Prevention. HIV Surveillance Report 2015. Vol. 27. CDC; 2017 https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2015-vol-27.pdf. [Accessed May 2017]. Note: Data for the year 2015 are preliminary (subject to change) because they are based on only a 6-month reporting delay. Data for the year 2015 should not be used when assessing trends Return to first Table 23 footnote † referrer Table 23 footnote ‡ National Centre in HIV Epidemiology and Clinical Research. HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2016. https://kirby.unsw.edu.au/sites/default/files/kirby/report/SERP_2016-Annual-Surveillance-Report_UPD170116.pdf. [Accessed 2017] Return to Table 23 footnote ‡ referrer Table 23 footnote § European Centre for Disease Prevention and Control/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2015. http://ecdc.europa.eu/en/publications/Publications/HIV-AIDS-surveillance-Europe-2015.pdf Return to Table 23 footnote § referrer

References

Footnote 1

Table footnote

Bourgeois AC, Edmunds M, Awan A, Jonah L, Varsaneux O, Siu W. HIV in Canada—Surveillance Report, 2016. Can Commun Dis Rep. 2017;43(12):248-55. https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-12-december-7-2017/hiv-canada-2016.html.

Return to footnote1 Referrer

Footnote 2

Table footnote

Schneider, E, Whitmore, S, Glynn, MK, Dominguez, K, Mitsch, A, McKenna, MT (2008). Revised Surveillance Case Definitions for HIV Infection Among Adults, Adolescents, and Children Aged < 18 Months and for HIV Infection and AIDS Among Children Aged 18 Months to < 13 Years—United States, MMWR [Internet] 2008 Dec 5 [cited 2016 Nov 8]; 57:1-16. http://www.cdc.gov/mmwr/pdf/rr/rr5710.pdf . [Accessed Nov 8, 2016]

Return to footnote2 Referrer

Table of contents

Page details

Date modified:: 2021-07-20

Language selection

Search

HIV in Canada—Supplementary tables, 2016

Web exclusive

HIV in Canada—Supplementary tables, 2016

Submit a manuscript

About CCDR

Browse

Page details